methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate

C50H55N7O8 — CID 170372189

IUPACmethyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate
SMILESCOC[C@H]1CC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC[C@H](C)N7C(=O)[C@@H](CC(=O)OC)C(C)C)nc65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1
InChIInChI=1S/C50H55N7O8/c1-27(2)35(22-43(58)63-5)48(59)57-28(3)12-17-40(57)47-52-38-16-14-31-20-37-34-15-13-32(19-33(34)26-65-42(37)21-36(31)45(38)54-47)39-23-51-46(53-39)41-18-29(25-62-4)24-56(41)49(60)44(55-50(61)64-6)30-10-8-7-9-11-30/h7-11,13-16,19-21,23,27-29,35,40-41,44H,12,17-18,22,24-26H2,1-6H3,(H,51,53)(H,52,54)(H,55,61)/t28-,29-,35-,40?,41?,44+/m0/s1
InChIKeyGLBNCWIXYQNRKG-SBKDRLHDSA-N
MW882.03 g/mol
LogP8.19
Rot. Bonds12

About methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate

methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate (PubChem CID 170372189) has the molecular formula C50H55N7O8 and a molecular weight of 882.03 g/mol. Its IUPAC name is methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate.

Molecular Properties

Compound Namemethyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate
PubChem CID170372189
Molecular FormulaC50H55N7O8
Molecular Weight882.03 g/mol
Exact Mass881.41
IUPAC Namemethyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate
SMILESCOC[C@H]1CC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC[C@H](C)N7C(=O)[C@@H](CC(=O)OC)C(C)C)nc65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1
InChIInChI=1S/C50H55N7O8/c1-27(2)35(22-43(58)63-5)48(59)57-28(3)12-17-40(57)47-52-38-16-14-31-20-37-34-15-13-32(19-33(34)26-65-42(37)21-36(31)45(38)54-47)39-23-51-46(53-39)41-18-29(25-62-4)24-56(41)49(60)44(55-50(61)64-6)30-10-8-7-9-11-30/h7-11,13-16,19-21,23,27-29,35,40-41,44H,12,17-18,22,24-26H2,1-6H3,(H,51,53)(H,52,54)(H,55,61)/t28-,29-,35-,40?,41?,44+/m0/s1
InChIKeyGLBNCWIXYQNRKG-SBKDRLHDSA-N
XLogP8.19
TPSA181.07 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds12
Heavy Atoms65
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500882.03
LogP ≤ 58.19
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Analyze methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate?
The IUPAC name of methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate (CID 170372189) is methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate.
What is the SMILES notation for methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate?
The canonical SMILES for methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate is COC[C@H]1CC(c2ncc(-c3ccc4c(c3)COc3cc5c(ccc6[nH]c(C7CC[C@H](C)N7C(=O)[C@@H](CC(=O)OC)C(C)C)nc65)cc3-4)[nH]2)N(C(=O)[C@H](NC(=O)OC)c2ccccc2)C1.
What is the InChIKey of methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate?
The InChIKey is GLBNCWIXYQNRKG-SBKDRLHDSA-N. The full InChI is InChI=1S/C50H55N7O8/c1-27(2)35(22-43(58)63-5)48(59)57-28(3)12-17-40(57)47-52-38-16-14-31-20-37-34-15-13-32(19-33(34)26-65-42(37)21-36(31)45(38)54-47)39-23-51-46(53-39)41-18-29(25-62-4)24-56(41)49(60)44(55-50(61)64-6)30-10-8-7-9-11-30/h7-11,13-16,19-21,23,27-29,35,40-41,44H,12,17-18,22,24-26H2,1-6H3,(H,51,53)(H,52,54)(H,55,61)/t28-,29-,35-,40?,41?,44+/m0/s1.
What are the key properties of methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate?
methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate has a molecular weight of 882.03 g/mol, XLogP of 8.19, 12 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (3S)-3-[(5S)-2-[17-[2-[(4S)-1-[(2R)-2-(methoxycarbonylamino)-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-6-yl]-5-methylpyrrolidine-1-carbonyl]-4-methylpentanoate is sourced from PubChem (CID 170372189), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).